Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:31 PM
Study NCT ID:
NCT06311851
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2024-03-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
Sponsor:
Pardis Noor Medical Imaging and Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-06
First Submit QC Date:
None
Study First Post Date:
2024-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-23
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED